Rational development of an attenuated recombinant cyprinid herpesvirus 3 vaccine using prokaryotic mutagenesis and in vivo bioluminescent imaging. (2015)
Attributed to:
Persistent Infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1004690
PubMed Identifier: 25700279
Publication URI: http://europepmc.org/abstract/MED/25700279
Type: Journal Article/Review
Volume: 11
Parent Publication: PLoS pathogens
Issue: 2
ISSN: 1553-7366